Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tempus AI
TEM
5
Block
XYZ
US Stock MarketDetailed Quotes
Intellia Therapeutics (NTLA)
- 12.500
- +0.630+5.31%
Close Jan 16 16:00 ET
- 12.500
- 0.0000.00%
Post 19:58 ET
1.45BMarket Cap-2.94P/E (TTM)
12.750High11.700Low5.75MVolume11.880Open11.870Prev Close71.58MTurnover5.22%Turnover RatioLossP/E (Static)115.83MShares28.25052wk High1.93P/B1.38BFloat Cap5.90052wk Low--Dividend TTM110.20MShs Float202.730Historical High--Div Yield TTM8.85%Range %5.900Historical Low12.450Avg Price1Lot Size
Intellia Therapeutics (NTLA) News
10 Health Care Stocks With Whale Alerts In Today's Session
One Buy! Cathie Wood Wraps Up Thursday With a Single Biotech Purchase
Intellia Therapeutics (NTLA) Receives a Hold From Bank of America Securities
Bernstein Downgrades Intellia Therapeutics(NTLA.US) to Hold Rating, Cuts Target Price to $13
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Universal Health (UHS)
Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 200-Day Moving Average
Cathie Wood Keeps Loading Up on This Biotech Stock — What's Driving the Steady Buying?
Cathie Wood Doubles Down on High-Potential Biotech Plays
Cathie Wood's Weekly Recap: Tilts to Advanced Air Mobility, Sells Meta
Express News | Intellia Therapeutics Inc : Bernstein Cuts Target Price to $13 From $14.5
Analysts Are Bullish on Top Healthcare Stocks: Intellia Therapeutics (NTLA), Roche Holding AG (RHHVF)
Insider Trades: Block, Broadcom, Micron Among Notable Names This Week
Cathie Wood's ARK Makes New Biotech Bets in Her Latest Trades — Here's What It Sold
Synopsys, Reddit, Intellia, Symbotic, Seagate Insider Shock
Fred Cohen Buys 303% More Intellia Therapeutics Shares
William Blair Maintains Intellia Therapeutics(NTLA.US) With Hold Rating
Intellia Updates Investors on Nex-Z Trial Safety Hold
GLP-1 Spillover, AI Empowerment... Could Biopharmaceuticals Become the 'Alternative' to Tech Stocks in 2026?
Citi noted that the indications for GLP-1 are expanding from weight management to cardiovascular and nervous system applications, alongside an anticipated expansion of Medicare coverage and the launch of Eli Lilly and Co’s oral medication orforglipron; AI is fully delivering cost and efficiency gains across R&D, production, and clinical stages; in addition, the DTP (Direct-to-Patient) model is reshaping distribution channels. As a result, the industry’s overall profitability and innovation conversion efficiency are significantly improving.
BofA Securities Maintains Intellia Therapeutics(NTLA.US) With Hold Rating, Cuts Target Price to $12
Intellia Therapeutics (NTLA) Gets a Hold From Bank of America Securities
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?